London · AIM · IPO · BVX
BiVictriX plc (to become BiVictriX Therapeutics plc)
BiVictriX plc (to become BiVictriX Therapeutics plc) (BVX) was admitted to AIM, raising £7.5M at 20p per share. Its market capitalization at admission was about £13.2M.
BiVictriX plc, to be renamed BiVictriX Therapeutics plc, is seeking admission to AIM with a £7.5 million placing.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- BVX
- Offer price
- 20p
- Raised
- £7.5M
- Market cap at admission
- £13.2M
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- New money versus sale shares
- Shares in issue at admission
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.